Literature DB >> 14633848

A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.

François Collard1, Ghislain Delpierre, Vincent Stroobant, Gert Matthijs, Emile Van Schaftingen.   

Abstract

Fructosamine-3-kinase (FN3K) is an enzyme that appears to be responsible for the removal of fructosamines from proteins. In this study, we report the sequence of human and mouse cDNAs encoding proteins sharing 65% sequence identity with FN3K. The genes encoding FN3K and FN3K-related protein (FN3K-RP) are present next to each other on human chromosome 17q25, and they both have a similar 6-exon structure. Northern blots of mouse tissues RNAs indicate a high level of expression of both genes in bone marrow, brain, kidneys, and spleen. Human FN3K-RP was transfected in human embryonic kidney (HEK) cells, and the expressed protein was partially purified by chromatography on Blue Sepharose. Unlike FN3K, FN3K-RP did not phosphorylate fructoselysine, 1-deoxy-1-morpholino-fructose, or lysozyme glycated with glucose. In a more systematic screening for potential substrates for FN3K-RP, we found, however, that both enzymes phosphorylated ketosamines with a D-configuration in C3 (psicoselysine, 1-deoxy-1-morpholino-psicose, 1-deoxy-1-morpholino-ribulose, lysozyme glycated with allose-the C3 epimer of glucose, or with ribose). Tandem mass spectrometry and nuclear magnetic resonance analysis of the product of phosphorylation of 1-deoxy-1-morpholino-psicose by FN3K-RP indicated that this enzyme phosphorylates the third carbon of the sugar moiety. These results indicate that FN3K-RP is a ketosamine-3-kinase (ketosamine-3-kinase 2). This enzyme presumably plays a role in freeing proteins from ribulosamines or psicosamines, which might arise in a several step process, from the reaction of amines with glucose and/or glycolytic intermediates. This role is shared by fructosamine-3-kinase (ketosamine-3-kinase 1), which has, in addition, the unique capacity to phosphorylate fructosamines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633848     DOI: 10.2337/diabetes.52.12.2888

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Increased protein glycation in fructosamine 3-kinase-deficient mice.

Authors:  Maria Veiga da-Cunha; Patrick Jacquemin; Ghislain Delpierre; Catherine Godfraind; Ivan Théate; Didier Vertommen; Frédéric Clotman; Frédéric Lemaigre; Olivier Devuyst; Emile Van Schaftingen
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

Review 2.  Advancing the development of glycated protein biosensing technology: next-generation sensing molecules.

Authors:  Miho Kameya; Akane Sakaguchi-Mikami; Stefano Ferri; Wakako Tsugawa; Koji Sode
Journal:  J Diabetes Sci Technol       Date:  2015-01-26

3.  Plant ribulosamine/erythrulosamine 3-kinase, a putative protein-repair enzyme.

Authors:  Juliette Fortpied; Rita Gemayel; Vincent Stroobant; Emile van Schaftingen
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

4.  Identification of protein-ribulosamine-5-phosphatase as human low-molecular-mass protein tyrosine phosphatase-A.

Authors:  Juliette Fortpied; Rita Gemayel; Didier Vertommen; Emile Van Schaftingen
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

5.  Fructosamine 3-kinase-related protein and deglycation in human erythrocytes.

Authors:  François Collard; Elsa Wiame; Niki Bergans; Juliette Fortpied; Didier Vertommen; Florent Vanstapel; Ghislain Delpierre; Emile Van Schaftingen
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

6.  Fructoselysine 3-epimerase, an enzyme involved in the metabolism of the unusual Amadori compound psicoselysine in Escherichia coli.

Authors:  Elsa Wiame; Emile Van Schaftingen
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

7.  Purification and identification of activating enzymes of CS-0777, a selective sphingosine 1-phosphate receptor 1 modulator, in erythrocytes.

Authors:  Kiyoaki Yonesu; Kazuishi Kubota; Masakazu Tamura; Shin-ichi Inaba; Tomohiro Honda; Chizuko Yahara; Nobuaki Watanabe; Tatsuji Matsuoka; Futoshi Nara
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

Review 8.  The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.

Authors:  Narasimha M Beeraka; Venugopal R Bovilla; Shalini H Doreswamy; Sujatha Puttalingaiah; Asha Srinivasan; SubbaRao V Madhunapantula
Journal:  Cancers (Basel)       Date:  2021-01-14       Impact factor: 6.639

9.  Genome-wide transcript and protein analysis highlights the role of protein homeostasis in the aging mouse heart.

Authors:  Isabela Gerdes Gyuricza; Joel M Chick; Gregory R Keele; Andrew G Deighan; Steven C Munger; Ron Korstanje; Steven P Gygi; Gary A Churchill
Journal:  Genome Res       Date:  2022-03-11       Impact factor: 9.438

10.  Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM.

Authors:  Giovanni Sartore; Eugenio Ragazzi; Silvia Burlina; Renata Paleari; Nino Cristiano Chilelli; Andrea Mosca; Francesca Avemaria; Annunziata Lapolla
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.